Literature DB >> 31802

Factors related to tardive dyskinesia.

G Chouinard, L Annable, A Ross-Chouinard, J N Nestoros.   

Abstract

The authors found a 31% incidence of tardive dyskinesia among 261 schizophrenic outpatients treated with neuroleptics. Multiple linear logistic regression analysis revealed a higher incidence of tardive dyskinesia among elderly patients, those with longer records of hospitalization, those for whom neuroleptic medication had little therapeutic effect, and those treated with fluphenazine. Patients manifesting tardive dyskinesia tended to have fewer parkinsonian symptoms than those without the disorder, especially when tremors and akathisia were excluded from consideration. Multiple linear regression analysis indicated that brain-damaged patients and male patients were more susceptible to severe forms of the disorder, even though these factors were not implicated in its initial appearance.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 31802     DOI: 10.1176/ajp.136.1.79

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  13 in total

1.  Topographic subtypes of tardive dyskinesia in schizophrenic patients aged less than 60 years: relationship to demographic, clinical, treatment, and neuropsychological variables.

Authors:  O Gureje
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-12       Impact factor: 10.154

Review 2.  Neuroleptic-induced akathisia: a review.

Authors:  L A Adler; B Angrist; S Reiter; J Rotrosen
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

3.  Ineffectiveness of deanol in tardive dyskinesia: a placebo controlled study.

Authors:  C de Montigny; G Chouinard; L Annable
Journal:  Psychopharmacology (Berl)       Date:  1979-11       Impact factor: 4.530

4.  Persistent catalepsy associated with severe dyskinesias in rats treated with chronic injections of haloperidol decanoate.

Authors:  T M Hyde; M F Egan; L L Wing; R J Wyatt; D R Weinberger; J E Kleinman
Journal:  Psychopharmacology (Berl)       Date:  1995-03       Impact factor: 4.530

5.  Persistent akathisia associated with early tardive dyskinesia.

Authors:  T R Barnes; W M Braude
Journal:  Postgrad Med J       Date:  1984-05       Impact factor: 2.401

6.  Basal ganglia abnormalities in tardive dyskinesia. Possible relationship with duration of neuroleptic treatment.

Authors:  P Dalgalarrondo; W F Gattaz
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1994       Impact factor: 5.270

7.  The impact of neuroleptic medication on tardive dyskinesia: a meta-analysis of published studies.

Authors:  H Morgenstern; W M Glazer; D Niedzwiecki; P Nourjah
Journal:  Am J Public Health       Date:  1987-06       Impact factor: 9.308

Review 8.  [The sensorimotor domain in the research domain criteria system: progress and perspectives].

Authors:  Dusan Hirjak; Stefan Fritze; Georg Northoff; Katharina M Kubera; Robert Christian Wolf
Journal:  Nervenarzt       Date:  2021-06-11       Impact factor: 1.214

Review 9.  Long-acting injectable risperidone for the treatment of schizophrenia: clinical perspectives.

Authors:  Hans-Jürgen Möller
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 10.  Long-term depot antipsychotics. A risk-benefit assessment.

Authors:  T R Barnes; D A Curson
Journal:  Drug Saf       Date:  1994-06       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.